toujeo solostar 300 unitsml solution for injection in a pre-filled pen
sanofi-aventis singapore pte. ltd. - insulin glargine - injection, solution - insulin glargine 300 units/ml
basalog one® solution for injection in a pre-filled pen 100 iuml
duopharma (singapore) pte ltd - insulin glargine - injection, solution - insulin glargine 100 iu/ml
abasaglar solution for injection
lilly france s.a.s. - insulin glargine - solution for injection - 100u/ml
caninsulin
schering-plough animal health limited - insulin - insulin 0.04 thou iu/ml - endocrine agent (hormone)
caninsulin 40 iu/ml inj. susp. i.m./s.c. vial
intervet international b.v. - insulin porcine 40 iu/ml - suspension for injection - 40 iu/ml - insulin zinc suspension, crystalline 28 iu/ml; insulin zinc suspension, amorphous 12 iu/ml - insulin (pork) - dog; cat
caninsulin 40 iu/ml inj. susp. s.c./i.m. cartr.
intervet international b.v. - insulin porcine 40 iu/ml - suspension for injection - 40 iu/ml - insulin zinc suspension, amorphous 12 iu/ml; insulin zinc suspension, crystalline 28 iu/ml - insulin (pork) - dog; cat
insulin lente mc
novo nordisk pharmaceuticals ltd - insulin zinc suspension, crystalline, bovine 100 iu/ml - solution for injection - 100 iu/ml - active: insulin zinc suspension, crystalline, bovine 100 iu/ml
insulin ultralente mc
novo nordisk pharmaceuticals ltd - insulin zinc suspension, crystalline, bovine 100 iu/ml - solution for injection - 100 iu/ml - active: insulin zinc suspension, crystalline, bovine 100 iu/ml
trulicity dulaglutide (rch) 1.5 mg/0.5 ml solution for injection prefilled pen
eli lilly australia pty ltd - dulaglutide, quantity: 1.5 mg - injection, solution - excipient ingredients: citric acid; water for injections; mannitol; polysorbate 80; sodium citrate dihydrate - type 2 diabetes mellitus: glycaemic control - trulicity is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus: ? as monotherapy. ? in combination with other glucose-lowering medicinal products including insulin, when these, together with diet and exercise, do not provide adequate glycaemic control (see section 5.1 for data with respect to different combinations).,type 2 diabetes mellitus: reduction in risk of major adverse cardiovascular events - trulicity is indicated as an adjunct to standard of care therapy to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus who have: ? established cardiovascular disease or ? multiple cardiovascular risk factors
optisulin solostar 100iu/ml insulin glargine (rbe) 3ml solution for injection injector pen
sanofi-aventis australia pty ltd - insulin glargine, quantity: 3.6378 mg/ml - injection, solution - excipient ingredients: water for injections; metacresol; glycerol; zinc chloride; sodium hydroxide; hydrochloric acid - insulin glargine is an insulin analogue indicated for once-daily subcutaneous administration in the treatment of type 1 diabetes mellitus in adults and children and type 2 diabetes mellitus in adults who require insulin for control of hyperglycaemia.